Cargando…

How I treat adverse effects of CAR-T cell therapy

Chimeric antigenreceptor (CAR) T cell therapy has demonstrated efficacy in B cell malignancies, particularly for acute lymphoblastic leukaemia (ALL) and non‑Hodgkin lymphomas. However, this regimen is not harmless and, in some patients, can lead to a multi organ failure. For this reason, the knowled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yáñez, Lucrecia, Alarcón, Ana, Sánchez-Escamilla, Miriam, Perales, Miguel-Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451454/ https://www.ncbi.nlm.nih.gov/pubmed/32839196 http://dx.doi.org/10.1136/esmoopen-2020-000746

Ejemplares similares

CAR T Cell Toxicity: Current Management and Future Directions
por: Yáñez, Lucrecia, et al.
Publicado: (2019)

How I treat cytopenias after CAR T-cell therapy
por: Jain, Tania, et al.
Publicado: (2023)

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
por: Cerrano, Marco, et al.
Publicado: (2020)

How I treat refractory CRS and ICANS after CAR T-cell therapy
por: Jain, Michael D., et al.
Publicado: (2023)

The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant
por: Alarcon Tomas, Ana, et al.
Publicado: (2021)

How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity
por: Santomasso, Bianca D., et al.
Publicado: (2023)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

CAR T-Cell Therapy: Adverse Events and Management
por: Adkins, Sherry
Publicado: (2019)

Estradiol uptake, toxicity, metabolism, and adverse effects on cadmium-treated amphibian embryos.
por: Fridman, Osvaldo, et al.
Publicado: (2004)

CAR-T Cell Therapy: From the Shop to Cancer Therapy
por: Uscanga-Palomeque, Ashanti Concepción, et al.
Publicado: (2023)

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
por: Wudhikarn, Kitsada, et al.
Publicado: (2022)

Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
por: Luo, Wenjing, et al.
Publicado: (2022)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Aparicio, Cristina, et al.
Publicado: (2021)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
por: Lin, Richard J., et al.
Publicado: (2023)

How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy
por: Gutierrez, Cristina, et al.
Publicado: (2023)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
por: Kim, Gloria B., et al.
Publicado: (2019)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

Adverse Cardiac Effects of CAR T-Cell Therapy: Characteristics, Surveillance, Management, and Future Research Directions
por: Dalal, Prarthana J., et al.
Publicado: (2022)

How CAR T Cells Breathe
por: Forcados, Christopher, et al.
Publicado: (2022)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
por: Li, Yanping, et al.
Publicado: (2022)

Born to survive: how cancer cells resist CAR T cell therapy
por: Lemoine, Jean, et al.
Publicado: (2021)

Combining chemotherapy with CAR-T cell therapy in treating solid tumors
por: Wang, Arthur Xuan, et al.
Publicado: (2023)

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
por: Zurko, Joanna, et al.
Publicado: (2022)

Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
por: Yang, Chieh, et al.
Publicado: (2023)

Oncolytic virus-derived type I interferon restricts CAR T cell therapy
por: Evgin, Laura, et al.
Publicado: (2020)

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
por: Wudhikarn, Kitsada, et al.
Publicado: (2020)

Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
por: Belin, Catherine, et al.
Publicado: (2020)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

CAR-T Cell Therapy
por: Ahmad, Aamir
Publicado: (2020)

Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
por: Nawas, Mariam T., et al.
Publicado: (2022)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

LPG Cars in a Car Park Environment—How to Make It Safe
por: Brzezińska, Dorota
Publicado: (2019)

CAR T cells for treating autoimmune diseases
por: Blache, Ulrich, et al.
Publicado: (2023)

Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy
por: Infante, Maria Stefania, et al.
Publicado: (2022)

CAR-T Cell Performance: How to Improve Their Persistence?
por: López-Cantillo, Gina, et al.
Publicado: (2022)

578. Infections in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) therapy
por: Tran, Nikki, et al.
Publicado: (2020)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
por: Wudhikarn, Kitsada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7q9n764lf1ogslsc2ijgam885